New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2014
09:18 EDTCSIQ, PLUG, SNE, ENZY, ISIS, PTX, FOSL, CLDX, MM, RUBI, TTWO, SODA, P, BMY, GSKOn The Fly: Pre-market Movers
HIGHER: Pernix Therapeutics (PTX), up 42% after acquiring TREXIMET tablets for migraine from GlaxoSmithKline (GSK)... Isis Pharmaceuticals (ISIS), up 9.6% after Phase 2 results for ISIS-GCGR for diabetes reported... Canadian Solar (CSIQ), up 1.7% after partnering with Ikea to build 3.6MW solar systems... Pandora (P), up 1.4% following upgrade at Raymond James... Rubicon Project (RUBI), up 22% after upgraded at Oppenheimer and RBC Capital following its Q1 earnings report... Celldex (CLDX), up 10.5% after announcing collaboration agreement with Bristol-Myers (BMY)... Millennial Media (MM), up 3.4% after CEO Barrett purchases 291K shares. LOWER: Sony (SNE), down 5.6% after reporting FY13 results, guiding to losses in FY14... DOWN AFTER EARNINGS: Fossil (FOSL), down 6.5%... Enzymotec (ENZY), down 8.6%... Plug Power (PLUG), down 6.6%... SodaStream (SODA), down 3.2%... Take-Two (TTWO), down 3.5%.
News For SNE;P;CLDX;PLUG;SODA;FOSL;CSIQ;TTWO;PTX;GSK;RUBI;ISIS;BMY;MM;ENZY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
May 18, 2015
14:11 EDTTTWOTake-Two technical notes before earnings
Subscribe for More Information
10:58 EDTRUBIRubicon Project management to meet with Needham
Subscribe for More Information
07:02 EDTCSIQCanadian Solar receives $44.4M non-recourse construction loan
Subscribe for More Information
05:13 EDTCSIQCanadian Solar to host investor day
Investor Day to be held in New York on May 18 at 9 am. Webcast Link
May 15, 2015
15:11 EDTGSKGlaxoSmithKline reports 16.12% stake in HTG Molecular
Subscribe for More Information
11:47 EDTSODAAnalysts mixed on Keurig after cold drink maker unveiling
Several research firms disagreed on the outlook for Keurig Green Mountain's (GMCR) upcoming at-home cold beverage maker, Keurig KOLD, after the company unveiled the product yesterday. SunTrust and Bernstein expressed major reservations about the product, while Susquehanna was more upbeat about the device and said the shares had reached a good entry point for investors. WHAT'S NEW: Keurig's management seemed to take a cautious view on the outlook for the device's sales, Bernstein analyst Ali Dibadj wrote. Additionally, the device and its pods "seemed a bit pricey" and large. However, the analyst, noting that the company hopes to eventually cut the price of the product to $200 from $300, called a potential $200 price point "more palatable for consumers." Furthermore, Dibadj says he has a hard time "fully understanding" the company's assertion that the device solves several problems. SunTrust analyst William Chappell, Jr. was impressed by the device's technology, but said he was concerned by the product's initial price and the investments that Keurig will have to make to launch the product. He kept a Neutral rating on the shares. BULLISH OUTLOOK:, Susquehanna analyst Pablo Zuanic said that most of the information on Kold was disappointing. The analyst said that he was disappointed by the device's high price and the fact that it will take a minute to make each drink. However, noting that SodaStream's (SODA) cold drink makers have penetrated 1.5% of U.S. households, the analyst says it is "not out of the question" that Kold can reach 3% household penetration in the U.S. by fiscal 2017-2018. If Kold does attain that milestone, Green Mountain's profits would double, the analyst stated. Zuanic remained upbeat on the company's long-term outlook and says that the stock is not currently reflecting any value for Kold. He believes that the stock has reached a good entry point, and kept a $140 price target and Positive rating on the shares. WHAT'S NOTABLE: Coca-Cola (KO) owns a 16% stake in Keurig Green Mountain. PRICE ACTION: In late morning trading, Keurig Green Mountain dropped 8.3% to $94.50, while SodaStream gained 2.5% to $22.25.
11:28 EDTPSpotify to roll out streaming service next week, CNBC reports
Subscribe for More Information
09:31 EDTGSKAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
09:11 EDTPTXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Bsquare (BSQR), up 34.2%... Applied Materials (AMAT), up 3.2%. ALSO HIGHER: Trillium Therapeutics (TRIL), up 13% after being initiated with an Outperform at Oppenheimer... Pernix Therapeutics (PTX), up 7.4% after announcing FDA approval of Treximet for use in pediatric patients... Advaxis (ADXS), up 4.4% after being initiated with a Buy at Jefferies... Netflix (NFLX), up 3.3% following a Bloomberg report that the company is in talks to enter China's online video market... Inovalon (INOV), up 2.9% after being upgraded to Buy from Neutral at Goldman. DOWN AFTER EARNINGS: El Pollo LoCo (LOCO), down 12.8%... King Digital (KING), down 8.3%. ALSO LOWER: PlasmaTech (PTBI), down 5.4% after filing to sell 1.93M shares for selling stockholders... Paycom Software (PAYC), down 7% after 8M share Spot Secondary priced at $36.25... Keurig Green Mountain (GMCR), down 5.9% after Keurig Kold investor presentation... 3D Systems (DDD), down 2.4% after CFO transition... Celladon (CLDN), down 5.1% after the CEO says that the company is evaluating strategic options.
08:48 EDTSODAKeurig Green Mountain Keurig Cold price points worrisome, says SunTrust
After attending Keurig Green Mountain's (GMCR) Keurig Kold launch event, SunTrust says it was impressed by the device's technology but concerned about its initial price points and near-term investments needed to launch the product. The firm keeps a Neutral rating on the stock. Coca-Cola (KO) owns a 16% stake in Keurig Green Mountain. SodaStream (SODA) develops and markets at-home cold beverage makers. :
08:05 EDTSODABernstein has reservations about Keurig Green Mountain's Keurig Kold
After attending Keurig Green Mountain's (GMCR) Keurig Kold launch event, Bernstein says that it has a hard time understanding the device's value proposition and sensed some caution from the company about how quickly the device's penetration will rise and be accretive to earnings. The firm says the device and pods seem a bit expensive, while the brewer and pods are large. The firm believes that the taste of the product's Diet Coke drink was off, although regular Coke and others were good. Coca-Cola (KO) owns a 16% stake in Keurig Green Mountain. SodaStream (SODA) develops and markets at-home cold beverage makers.
07:31 EDTPTXPernix announces FDA approval of Treximet for use in pediatric patients
Pernix Therapeutics Holdings announced that the FDA has approved TREXIMET for use in pediatric patients 12 years of age and older for the acute treatment of migraine with or without aura. TREXIMET is the first approved combination prescription medicine, and the first to contain sumatriptan, for the treatment of acute migraine attacks in pediatric patients. The recommended dose for pediatric patients 12 years of age and older is a single tablet of TREXIMET 10/60 mg per 24-hour period and the maximum recommended dose is 85/500 mg per 24-hour period. The recommended dose for adults is a single tablet of TREXIMET 85/500 mg.
06:13 EDTPPandora to appeal unfavorable court decision against BMI, AP reports
Subscribe for More Information
05:52 EDTTTWOApril NPD video game software sales rose 13%, says Piper Jaffray
Piper Jaffray notes April NPD video game software sales increased 13% year-over-year with next-generation software revenue up 200% versus the prior year. Piper keeps Overweight ratings on Activision Blizzard (ATVI), Electronic Arts (EA), GameStop (GME) and Take-Two (TTWO).
May 14, 2015
18:41 EDTSODAKeurig Green Mountain drops after Keurig Kold investor presentation
Subscribe for More Information
15:21 EDTTTWOTake-Two June volatility elevated into Q4 and outlook
Take-Two June call option implied volatility is at 43, September is at 38, December is at 35; compared to its 90-average of 39, suggesting large near term price movement in to the expected release of Q4 results on May 18.
11:03 EDTBMYBristol-Myers treatment of progressive supranuclear palsy granted orphan status
Subscribe for More Information
10:41 EDTBMYAnalysts upbeat on Amgen's Kyprolis after ASCO abstracts
Subscribe for More Information
09:22 EDTBMYLeerink pharma/biotech analysts hold an analyst/industry conference call
Subscribe for More Information
09:09 EDTBMYBristol-Myers down 1.3% after release of ASCO abstracts
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use